Wednesday, March 01, 2017 10:43:23 PM
By Chris Sandburg / in Biotech & Pharma, Momentum & Growth, Momentum Stocks, Stocks / on Wednesday, 01 Mar 2017 11:07 AM
https://www.insiderfinancial.com/heres-our-take-on-premier-biomedical-inc-otcmktsbieis-strategy/119870/
IN THIS ARTICLE:
...The company’s extracorporeal platform is targeting a host of different indication types, with the major blockbusters all included – Alzheimer’s, oncology, CNS, autoimmune etc. These are great from a long term potential perspective...
This should bridge the gap between pre clinical and clinical development in the blockbusters described above... The pain relief patches consist of a proprietary CBD hemp oil formulation with 20% more CBD, and a patch area 30% larger, than competition. They are designed to provide up to 96 hours of continuous pain relief. The roll-on applicator contains 110 mg of Premier’s proprietary CBD formulation, 10% more CBD than the closest competitor. These are pretty decent specs, and there’s data in place that supports efficacy of both products. The key point here, however, is that these products don’t need FDA approval before commercialization. That’s the beauty of CBD rooted pain management, and that’s the core justification (in our eyes) for Premier moving into the space.
... These few distribution agreements aren’t going transform Premier’s financials overnight. They are, however, the first concrete reports that we’ve got that outlets are willing to hold Premier’s products on-shelf, and they represent (according to the company) the start of a much bigger distribution rollout.
As news of further outlets stocking the roll on and the patch hit press, we should see Premier pick up increased speculative interest, and with this added volume, we should see some strength.
As the products sell, we should also see some top line increase, and this will eat away at the dilutive risk (which is pretty large right now)...
FEATURED Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM